Definitive Contract W911SR23C0019
Award Date
6/27/23
Potential Completion Date
7/2/25
Potential Value
$1.1M
Funding Federal Agency
Joint PEO Chemical and Biological Defense
Contracting Federal Agency
ACC Aberdeen Proving Ground
Awardee
CMC Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AC12 - National Defense R&D Services; Department Of Defense - Military; Applied Research
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Solon, OH 44139, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a $1,466,682.62 Firm Fixed Price contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to CMC Pharmaceuticals, Inc. (CMC), a woman-owned small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for drug formulation development and complex drug delivery system services related to pharmaceutical products such as atropine sulfate formulations and scopolamine hydrobromide vials. CMC has...
This firm fixed-price purchase order was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to CMC Pharmaceuticals, Inc., a woman-owned small business, under the Small Business Innovation Research (SBIR) Program. The $167,076.48 contract is for Phase I research and development to formulate and develop manufacturing processes for a multi-dose vial presentation of scopolamine hydrobromide trihydrate containing antimicrobial preservatives....
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $149,268.80 Small Business Innovation Research (SBIR) Program Phase I contract to CMC Pharmaceuticals, Inc., a woman-owned small business. This firm fixed price contract is for research and development related to a SBIR topic on chemical/biological defense. As a small business, CMC Pharmaceuticals will provide drug formulation development and complex drug delivery system services to...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,460.60 firm fixed-price delivery order is for the procurement of an Antidote Treatment Kit, Cyanide Sodium N, which is a specialized medical product used to treat cyanide poisoning. The contract has an ultimate completion date of November 13, 2024. DMS...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $11,587.21. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order (SPE2DX24FKWEA) valued at $9,901.41. The contract was awarded on July 23, 2024, by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, with an ultimate completion date of July 23, 2024. The contract covers the delivery of pharmaceutical products, including medications such as ondansetron HCL, to support the medical supply needs of the U.S....
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a single-award indefinite delivery contract (IDC) under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order worth $1,492.79. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, which provides pharmaceutical products and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract covers the delivery of various pharmaceutical items, including medications like flumazenil injections,...
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $2,687.00 firm fixed-price contract is for the supply of a pharmaceutical product, Cyanokit 5 gram vials, with a period of performance through September 4, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,010.72, was awarded by the Defense Logistics Agency (DLA) under its Medical Supply Chain division. The award is for the delivery of Atropine Sulfate Ophthalmic, a pharmaceutical product, with a completion date of January 18, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with...